一个分数顺序的肺癌数学模型,包含综合治疗方法
David Amilo1,2, Bilgen Kaymakamzade3,4, Evren Hincal3,4
1Department of Mathematics, Near East University, Nicosia, Cyprus. amilodavid.ikechukwu@neu.edu.tr.
Scientific reports
|August 1, 2023
概括
这项研究使用微积分计算来模拟肺癌治疗,将手术和免疫疗法结合起来. 研究结果显示,联合治疗显著改善了患者的治疗结果,提供了个性化的治疗方法.
科学领域:
- 数学瘤学数学瘤学
- 控制理论 控制理论
- 免疫治疗是一种免疫疗法.
背景情况:
- 肺癌的动态很复杂,需要先进的建模来有效治疗.
- 当前的手术和免疫疗法等治疗方法在单独使用时存在局限性.
研究的目的:
- 通过使用分数顺序模型研究手术和免疫治疗对肺癌的协同效应.
- 根据瘤反应来设计治疗剂量的最佳控制系统.
- 增强针对肺癌患者的个性化治疗策略.
主要方法:
- 对肺癌动态的分数顺序数学模型的开发.
- 控制理论和庞特里亚金的最大原则的应用,以优化治疗.
- 计算模拟用于分析治疗疗效和参数灵敏度.
主要成果:
- 基本的繁殖数 (R0) 是2.6,表明疾病的传染性.
- 与单一疗法相比,联合疗法显示出优越的患者结局.
- 模型灵敏度分析确定了影响治疗有效性的关键参数,包括癌症干细胞分裂和分化率.
结论:
- 分数顺序建模与控制理论相结合,为优化肺癌治疗提供了一个强大的框架.
- 综合性手术和免疫治疗,以最佳控制为指导,为改善患者存活率提供了一个有希望的策略.
- 这种方法可以通过考虑个体瘤特征和患者因素来实现个性化治疗规划.
更多相关视频
相关概念视频
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384


